Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-007065

CVP, TAVR sold 619 shares at $92.03 ($56,967)

  • CVP, TAVR acquired 619 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, TAVR

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-11 Exercise or conversion : show line 1 in the form 10b5-1 +619 $72.68 $44,989 40,652.91 D
2026-08-11 Sale : show line 2 in the form 10b5-1 −619 $92.03 $56,967 40,033.91 D
Open-market sales · 619 sh · avg $92.03 · $56,967

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-11 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −619 4,333 D
Loading xslF345X06/doc4.xml…